0001654954-22-007804.txt : 20220601 0001654954-22-007804.hdr.sgml : 20220601 20220601160537 ACCESSION NUMBER: 0001654954-22-007804 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20220601 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220601 DATE AS OF CHANGE: 20220601 FILER: COMPANY DATA: COMPANY CONFORMED NAME: cbdMD, Inc. CENTRAL INDEX KEY: 0001644903 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 473414576 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38299 FILM NUMBER: 22987344 BUSINESS ADDRESS: STREET 1: 8845 RED OAK BOULEVARD CITY: CHARLOTTE STATE: NC ZIP: 28217 BUSINESS PHONE: 704-445-3060 MAIL ADDRESS: STREET 1: 8845 RED OAK BOULEVARD CITY: CHARLOTTE STATE: NC ZIP: 28217 FORMER COMPANY: FORMER CONFORMED NAME: Level Brands, Inc. DATE OF NAME CHANGE: 20170202 FORMER COMPANY: FORMER CONFORMED NAME: LEVEL BEAUTY GROUP, INC. DATE OF NAME CHANGE: 20150611 8-K 1 ycbd_8k.htm FORM 8-K ycbd_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) June 1, 2022

 

ycbd_8kimg1.jpg

 

cbdMD, INC.

(Exact name of registrant as specified in its charter)

 

North Carolina

 

001-38299

 

47-3414576

(State or other jurisdiction of

incorporation or organization)

 

(Commission File Number)

 

(I.R.S. Employer

Identification No.)

 

8845 Red Oak Blvd, Charlotte, NC  28217

(Address of principal executive offices)(Zip Code)

 

Registrant's telephone number, including area code:  (704) 445-3060

 

_______________________________________________

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

common

 

YCBD

 

NYSE American

8% Series A Cumulative Convertible Preferred Stock

 

YCBD PR A

 

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

  

Item 8.01 Other Events. 

 

On June 1, 2022 cbdMD, Inc. issued a press release addressing matters relating to its chief executive officer.  A copy of this press release is filed hereto as Exhibit 99.1 and is incorporated herein by reference.   

 

Item 9.01 Financial Statements and Exhibits. 

 

(d) Exhibits.

 

Incorporated by Reference

Filed or

Furnished

Herewith

No.

Exhibit Description

Form

Date Filed

Number

 

 

 

 

 

 

 

 

 

 

 

99.1

 

Press release issued June 1, 2022

 

 

 

 

 

 

 

Filed

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

cbdMD, Inc.

 

 

 

 

 

Date: June 1, 2022

By:

/s/ T. Ronan Kennedy

 

 

 

T. Ronan Kennedy, Chief Financial Officer and Chief Operating Officer

 

 

 

3

 

EX-99.1 2 ycbd_ex991.htm PRESS RELEASE ISSUED JUNE 1, 2022 ycbd_ex991.htm

EXHIBIT 99.1

 

cbdMD, Inc. Addresses Executive SEC Matter

 

June 1, 2022, cbdMD, Inc. (NYSE American: YCBD, YCBDpA), announced today that the company has learned that the Securities and Exchange Commission (“SEC”) has brought a civil action against Martin Sumichrast, relating to a private company previously managed by Mr. Sumichrast, which was dissolved in early 2020. The company notes that the complaint does not allege any wrongdoing by cbdMD, Inc. However, the complaint states that Mr. Sumichrast engaged in a series of transactions with entities in which he personally had a conflict of interest, including the company during 2017 and 2018.  The SEC seeks injunctive and equitable relief, including an officer-and-director bar against Mr. Sumichrast.  Mr. Sumichrast serves as the company’s chairman and chief executive officer.  The company’s board of directors has formed a special committee of independent directors to review the SEC action to evaluate the consequences on the company, if any, and, together with counsel, promptly recommend an appropriate course of action to the board. The special committee will also endeavor to monitor the action.  Mr. Sumichrast has agreed to cooperate fully with the special committee while focusing on executing cbdMD’s commitment to remaining one of the nation’s leading and most highly trusted and recognized CBD companies.

 

About cbdMD, Inc.

 

cbdMD, Inc. is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-freeCBD products as well as our new Full Spectrum products. Our cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD sleep aids and CBD drink mixes. Our Paw CBD brand of pet products includes over 45 SKUs of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and our CBD Botanicals brand of beauty and skincare products features 15 SKUs, including facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care. To learn more about cbdMD and their comprehensive line of U.S. grown, THC-free1 CBD oil and Full Spectrum products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD’s products.

 

EX-101.SCH 3 ycbd-20220601.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ycbd-20220601_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity Ex Transition Period Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Local Phone Number Security 12b Title Trading Symbol Security Exchange Name EX-101.CAL 5 ycbd-20220601_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 ycbd-20220601_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 ycbd-20220601_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE GRAPHIC 8 ycbd_8kimg1.jpg begin 644 ycbd_8kimg1.jpg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htm IDEA: XBRL DOCUMENT v3.22.1
Cover
Jun. 01, 2022
Cover [Abstract]  
Entity Registrant Name cbdMD, INC.
Entity Central Index Key 0001644903
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company true
Document Period End Date Jun. 01, 2022
Entity Ex Transition Period false
Entity File Number 001-38299
Entity Incorporation State Country Code NC
Entity Tax Identification Number 47-3414576
Entity Address Address Line 1 8845 Red Oak Blvd
Entity Address City Or Town Charlotte,
Entity Address State Or Province NC
Entity Address Postal Zip Code 28217
City Area Code 704
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Local Phone Number 445-3060
Security 12b Title 8% Series A Cumulative Convertible Preferred Stock
Trading Symbol YCBD
Security Exchange Name NYSEAMER
XML 10 ycbd_8k_htm.xml IDEA: XBRL DOCUMENT 0001644903 2022-06-01 2022-06-01 iso4217:USD shares iso4217:USD shares 0001644903 false 8-K 2022-06-01 cbdMD, INC. NC 001-38299 47-3414576 8845 Red Oak Blvd Charlotte, NC 28217 704 445-3060 false false false false YCBD NYSEAMER 8% Series A Cumulative Convertible Preferred Stock true false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 23 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://cbdmd.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ycbd_8k.htm ycbd-20220601.xsd ycbd-20220601_cal.xml ycbd-20220601_def.xml ycbd-20220601_lab.xml ycbd-20220601_pre.xml ycbd_ex991.htm ycbd_8kimg1.jpg http://xbrl.sec.gov/dei/2021q4 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ycbd_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "ycbd-20220601_cal.xml" ] }, "definitionLink": { "local": [ "ycbd-20220601_def.xml" ] }, "inline": { "local": [ "ycbd_8k.htm" ] }, "labelLink": { "local": [ "ycbd-20220601_lab.xml" ] }, "presentationLink": { "local": [ "ycbd-20220601_pre.xml" ] }, "schema": { "local": [ "ycbd-20220601.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ycbd", "nsuri": "http://cbdmd.com/20220601", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "ycbd_8k.htm", "contextRef": "From2022-06-01to2022-06-01", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://cbdmd.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "ycbd_8k.htm", "contextRef": "From2022-06-01to2022-06-01", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://cbdmd.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 17 0001654954-22-007804-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-22-007804-xbrl.zip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